Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131).
about
ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia responseA non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice.ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes.ARA 290 for treatment of small fiber neuropathy in sarcoidosis.Ketamine for pain.Targeting the innate repair receptor to treat neuropathy.
P2860
Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131).
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Ketamine does not produce reli ...... the β-common receptor (CD131).
@ast
Ketamine does not produce reli ...... the β-common receptor (CD131).
@en
type
label
Ketamine does not produce reli ...... the β-common receptor (CD131).
@ast
Ketamine does not produce reli ...... the β-common receptor (CD131).
@en
prefLabel
Ketamine does not produce reli ...... the β-common receptor (CD131).
@ast
Ketamine does not produce reli ...... the β-common receptor (CD131).
@en
P2093
P2860
P1433
P1476
Ketamine does not produce reli ...... the β-common receptor (CD131)
@en
P2093
Albert Dahan
Carla Cerami Hand
Hyung-Suk Kim
Leon Aarts
Maarten Swartjes
Marieke Niesters
P2860
P304
P356
10.1371/JOURNAL.PONE.0071326
P407
P577
2013-08-01T00:00:00Z